Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1626

1.

Potassium octatitanate fibers induce persistent lung and pleural injury and are possibly carcinogenic in male Fischer 344 rats.

Abdelgied M, El-Gazzar AM, Alexander DB, Alexander WT, Numano T, Iigou M, Naiki-Ito A, Takase H, Abdou KA, Hirose A, Taquahashi Y, Kanno J, Tsuda H, Takahashi S.

Cancer Sci. 2018 May 17. doi: 10.1111/cas.13643. [Epub ahead of print]

2.

A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells.

Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M.

Cancer Med. 2018 May 7. doi: 10.1002/cam4.1516. [Epub ahead of print]

3.

Effect of molecular hydrogen on uterine inflammation during preterm labour.

Nakano T, Kotani T, Imai K, Iitani Y, Ushida T, Tsuda H, Li H, Iwase A, Toyokuni S, Kikkawa F.

Biomed Rep. 2018 May;8(5):454-460. doi: 10.3892/br.2018.1082. Epub 2018 Mar 27.

4.

Interleukin-33 is expressed in the lesional epidermis in herpes virus infection but not in verruca vulgaris.

Jin M, Komine M, Tsuda H, Oshio T, Ohtsuki M.

J Dermatol. 2018 Apr 25. doi: 10.1111/1346-8138.14334. [Epub ahead of print]

PMID:
29696682
5.

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

Soyama H, Miyamoto M, Takano M, Iwahashi H, Kato K, Sakamoto T, Kuwahara M, Ishibashi H, Matuura H, Yoshikawa T, Aoyama T, Tsuda H, Furuya K.

In Vivo. 2018 May-Jun;32(3):597-602.

PMID:
29695566
6.

Ovarian cancer therapeutic potential of glutamine depletion based on GS expression.

Furusawa A, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J, Inoue J.

Carcinogenesis. 2018 Apr 2. doi: 10.1093/carcin/bgy033. [Epub ahead of print]

PMID:
29617730
7.

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

Yoshikawa T, Miyamoto M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Nagaoka I, Tsuda H, Furuya K, Takano M.

Oncol Lett. 2018 Apr;15(4):5772-5780. doi: 10.3892/ol.2018.8028. Epub 2018 Feb 12.

8.

Computerized Hammer Sounding Interpretation for Concrete Assessment with Online Machine Learning.

Ye J, Kobayashi T, Iwata M, Tsuda H, Murakawa M.

Sensors (Basel). 2018 Mar 9;18(3). pii: E833. doi: 10.3390/s18030833.

9.

Altered proteomic profile in umbilical arterial serum from mothers with schizophrenia.

Moriyama Y, Kotani T, Ushida T, Imai K, Nakano T, Tsuda H, Kikkawa F.

Schizophr Res. 2018 Mar 3. pii: S0920-9964(18)30101-4. doi: 10.1016/j.schres.2018.02.024. [Epub ahead of print] No abstract available.

PMID:
29510929
10.

Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.

Tsuda H, Su CA, Tanaka T, Ayasoufi K, Min B, Valujskikh A, Fairchild RL.

JCI Insight. 2018 Feb 22;3(4). pii: 96940. doi: 10.1172/jci.insight.96940. [Epub ahead of print]

11.

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.

Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa T, Tsuda H, Furuya K.

J Gynecol Oncol. 2018 Mar;29(2):e20. doi: 10.3802/jgo.2018.29.e20. Epub 2017 Dec 22.

12.

Sialyl Lewisx expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer.

Yamadera M, Shinto E, Tsuda H, Kajiwara Y, Naito Y, Hase K, Yamamoto J, Ueno H.

Oncol Lett. 2018 Jan;15(1):221-228. doi: 10.3892/ol.2017.7340. Epub 2017 Nov 3.

13.

Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma.

Matuura H, Miyamoto M, Takano M, Soyama H, Aoyama T, Yoshikawa T, Kato K, Sakamoto T, Kuwahara M, Takasaki K, Ishibashi H, Iwahashi H, Tsuda H, Furuya K.

Anticancer Res. 2018 Feb;38(2):717-722.

PMID:
29374695
14.

Measurement of endometrial thickness in premenopausal women in office gynecology.

Tsuda H, Ito YM, Todo Y, Iba T, Tasaka K, Sutou Y, Hirai K, Dozono K, Dobashi Y, Manabe M, Sakamoto T, Yamamoto R, Ueda K, Akatsuka M, Kiyozuka Y, Nagai N, Imai M, Kobiki K, Fujita H, Itamochi H, Oshita T, Kawarada T, Hatae M, Yokoyama Y.

Reprod Med Biol. 2017 Sep 16;17(1):29-35. doi: 10.1002/rmb2.12062. eCollection 2018 Jan.

15.

The expression of Toll-like receptor 5 in preterm histologic chorioamnionitis.

Moroi H, Kotani T, Miki R, Tsuda H, Mizuno M, Ito Y, Ushida T, Imai K, Nakano T, Li H, Sumigama S, Yamamoto E, Iwase A, Kikkawa F.

J Clin Biochem Nutr. 2018 Jan;62(1):63-67. doi: 10.3164/jcbn.16-103. Epub 2017 Oct 11.

16.

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.

Hirasawa A, Imoto I, Naruto T, Akahane T, Yamagami W, Nomura H, Masuda K, Susumu N, Tsuda H, Aoki D.

Oncotarget. 2017 Nov 28;8(68):112258-112267. doi: 10.18632/oncotarget.22733. eCollection 2017 Dec 22.

17.

Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma.

Ishibashi H, Takano M, Miyamoto M, Soyama H, Matsuura H, Aoyama T, Yoshikawa T, Kato K, Tsuda H, Furuya K.

Mol Clin Oncol. 2017 Dec;7(6):1027-1031. doi: 10.3892/mco.2017.1468. Epub 2017 Oct 23.

18.

Isolated hemicape-like sensory disturbance caused by a cortical infarction.

Takahashi K, Aizawa Y, Ishihara M, Tsuda H.

J Gen Fam Med. 2017 Jun 15;18(6):448-449. doi: 10.1002/jgf2.95. eCollection 2017 Dec. No abstract available.

19.

Motor weakness and sensory disturbance of the shoulder due to a cortical infarction.

Takahashi K, Yagi K, Tsuda H.

J Gen Fam Med. 2017 May 8;18(5):303-304. doi: 10.1002/jgf2.70. eCollection 2017 Oct. No abstract available.

20.

Isolated astasia caused by a localized infarction in the suprathalamic white matter.

Takahashi K, Osaka A, Tsuda H, Ogasawara H.

J Gen Fam Med. 2017 Apr 13;18(5):275-278. doi: 10.1002/jgf2.54. eCollection 2017 Oct.

21.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.

Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Carcinogenesis. 2018 Feb 9;39(2):263-271. doi: 10.1093/carcin/bgx139.

PMID:
29228320
22.

Calibrated phase-shifting digital holography based on a dual-camera system.

Xia P, Wang Q, Ri S, Tsuda H.

Opt Lett. 2017 Dec 1;42(23):4954-4957. doi: 10.1364/OL.42.004954.

PMID:
29216154
23.

Generalized pustular psoriasis in a 92-year-old man with a homozygous nonsense mutation in IL36RN.

Ueda Y, Komine M, Kamiya K, Tsuda H, Maekawa T, Murata S, Ohtsuki M.

J Dermatol. 2018 Mar;45(3):326-328. doi: 10.1111/1346-8138.14132. Epub 2017 Dec 7.

PMID:
29215143
24.

Relationship between plasma protein S levels and apolipoprotein C-II in Japanese middle-aged obese women and young nonobese women.

Otsuka Y, Ueda M, Nakazono E, Tsuda T, Jin X, Noguchi K, Sata S, Miyazaki H, Abe S, Imai K, Iwamoto M, Masuda T, Moriguchi R, Nakano S, Tsuda H.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):39-47. doi: 10.1097/MBC.0000000000000662.

PMID:
29206648
25.

Role of catalytic iron and oxidative stress in nitrofen-induced congenital diaphragmatic hernia and its amelioration by Saireito (TJ-114).

Hirako S, Tsuda H, Ito F, Okazaki Y, Hirayama T, Nagasawa H, Nakano T, Imai K, Kotani T, Kikkawa F, Toyokuni S.

J Clin Biochem Nutr. 2017 Nov;61(3):176-182. doi: 10.3164/jcbn.17-17. Epub 2017 Sep 5.

26.

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K.

Med Oncol. 2017 Nov 22;34(12):201. doi: 10.1007/s12032-017-1058-3.

PMID:
29168038
27.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.

Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Oncotarget. 2017 Sep 20;8(48):84112-84122. doi: 10.18632/oncotarget.21109. eCollection 2017 Oct 13.

28.

Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.

Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Nakanishi T, Hasumi Y, Iwata T, Baba T, Nogawa T, Kudaka W, Kaneda H, Ono S, Saito F, Taniguchi Y, Okada S, Mizuno M, Onda T, Yaegashi N.

Gynecol Oncol. 2018 Jan;148(1):139-146. doi: 10.1016/j.ygyno.2017.10.027. Epub 2017 Nov 4.

PMID:
29113721
29.

Visualization and automatic detection of defect distribution in GaN atomic structure from sampling Moiré phase.

Wang QH, Ri S, Tsuda H, Kodera M, Suguro K, Miyashita N.

Nanotechnology. 2017 Oct 17;28(45):455704. doi: 10.1088/1361-6528/aa8d83. [Epub ahead of print]

PMID:
29039360
30.

TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.

Kobayashi A, Kobayashi S, Miyai K, Osawa Y, Horiuchi T, Kato S, Maekawa T, Yamamura T, Watanabe J, Sato K, Tsuda H, Kimura F.

Int J Hematol. 2018 Feb;107(2):222-229. doi: 10.1007/s12185-017-2345-7. Epub 2017 Oct 12.

PMID:
29027124
31.

Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy.

Maruta E, Wang J, Kotani T, Tsuda H, Nakano T, Imai K, Sumigama S, Niwa Y, Mitsui T, Yoshida S, Yamashita M, Nawa A, Tamakoshi K, Kajiyama H, Kikkawa F.

Clin Chim Acta. 2017 Dec;475:70-77. doi: 10.1016/j.cca.2017.10.007. Epub 2017 Oct 10.

PMID:
29024618
32.

Idiopathic thrombosis.

Tsuda H.

Rinsho Ketsueki. 2017;58(10):2087-2095. doi: 10.11406/rinketsu.58.2087. Japanese.

PMID:
28978853
33.

Visualization and automatic detection of defect distribution in GaN atomic structure from sampling Moiré phase.

Wang Q, Ri S, Tsuda H, Kodera M, Suguro K, Miyashita N.

Nanotechnology. 2017 Sep 19. doi: 10.1088/1361-6528/aa8d83. [Epub ahead of print]

PMID:
28925373
34.

CAY10591, a SIRT1 activator, suppresses cell growth, invasion, and migration in gingival epithelial carcinoma cells.

Murofushi T, Tsuda H, Mikami Y, Yamaguchi Y, Suzuki N.

J Oral Sci. 2017;59(3):415-423. doi: 10.2334/josnusd.16-0696.

35.

Decoding finger movement in humans using synergy of EEG cortical current signals.

Yoshimura N, Tsuda H, Kawase T, Kambara H, Koike Y.

Sci Rep. 2017 Sep 12;7(1):11382. doi: 10.1038/s41598-017-09770-5.

36.

Ectopic Hamartomatous Thymoma: A Review Of The Literature With Report Of New Cases And Proposal Of A New Name: Biphenotypic Branchioma.

Sato K, Thompson LDR, Miyai K, Kono T, Tsuda H.

Head Neck Pathol. 2018 Jun;12(2):202-209. doi: 10.1007/s12105-017-0854-6. Epub 2017 Sep 6.

PMID:
28879635
37.

Inter-observer agreement among pathologists in grading the pathological response to neoadjuvant chemotherapy in breast cancer.

Yamaguchi T, Mukai H, Akiyama F, Arihiro K, Masuda S, Kurosumi M, Kodama Y, Horii R, Tsuda H.

Breast Cancer. 2018 Jan;25(1):118-125. doi: 10.1007/s12282-017-0799-3. Epub 2017 Aug 30.

PMID:
28856554
38.

Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.

Tsuda H, Tsuji T, Tsuji M, Yamasaki H.

Ann Hematol. 2017 Nov;96(11):1915-1920. doi: 10.1007/s00277-017-3095-6. Epub 2017 Aug 14.

PMID:
28808759
39.

Two-dimensional Moiré phase analysis for accurate strain distribution measurement and application in crack prediction.

Wang Q, Ri S, Tsuda H, Koyama M, Tsuzaki K.

Opt Express. 2017 Jun 12;25(12):13465-13480. doi: 10.1364/OE.25.013465.

PMID:
28788891
40.

Simulation training is useful for shortening the decision-to-delivery interval in cases of emergent cesarean section.

Iitani Y, Tsuda H, Ito Y, Moriyama Y, Nakano T, Imai K, Kotani T, Kikkawa F.

J Matern Fetal Neonatal Med. 2017 Aug 16:1-5. doi: 10.1080/14767058.2017.1365126. [Epub ahead of print]

PMID:
28782405
41.

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

Kitano A, Ono M, Yoshida M, Noguchi E, Shimomura A, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Kinoshita T, Fujiwara Y, Tsuda H, Tamura K.

ESMO Open. 2017 May 2;2(2):e000150. doi: 10.1136/esmoopen-2016-000150. eCollection 2017.

42.

Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.

Horiguchi A, Shinchi M, Nakamura A, Wada T, Ito K, Asano T, Shinmoto H, Tsuda H, Ishihara M.

Urology. 2017 Oct;108:212-219. doi: 10.1016/j.urology.2017.07.008. Epub 2017 Jul 19.

PMID:
28735020
43.

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.

Yoshikawa T, Takano M, Miyamoto M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Sasa H, Nagaoka I, Tsuda H, Furuya K.

Cancer Chemother Pharmacol. 2017 Sep;80(3):555-561. doi: 10.1007/s00280-017-3395-5. Epub 2017 Jul 19.

PMID:
28726081
44.

Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.

Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Tumour Biol. 2017 Jun;39(6):1010428317700409. doi: 10.1177/1010428317700409.

PMID:
28618928
45.

Micro/Nano-scale Strain Distribution Measurement from Sampling Moiré Fringes.

Wang Q, Ri S, Tsuda H.

J Vis Exp. 2017 May 23;(123). doi: 10.3791/55739.

PMID:
28570517
46.

Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.

Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Anticancer Res. 2017 Jun;37(6):3129-3135.

PMID:
28551654
47.

Interannual study of spot urine-evaluated sodium excretion in young Japanese women.

Yasutake K, Moriguchi R, Kajiyama T, Miyazaki H, Abe S, Masuda T, Imai K, Iwamoto M, Tsuda H, Obe M, Kawate H, Ueno H, Ono M, Goromaru R, Ohe K, Enjoji M, Tsuchihashi T, Nakano S.

J Clin Hypertens (Greenwich). 2017 Jul;19(7):653-660. doi: 10.1111/jch.13025. Epub 2017 May 23.

48.

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Soyama H, Kato K, Ishibashi H, Iwahashi H, Nakatsuka M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Goto T, Sasa H, Nagaoka I, Tsuda H, Furuya K.

Cancer Chemother Pharmacol. 2017 Jul;80(1):65-69. doi: 10.1007/s00280-017-3332-7. Epub 2017 May 10.

PMID:
28493032
49.

Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy.

Tanabe Y, Tsuda H, Yoshida M, Yunokawa M, Yonemori K, Shimizu C, Yamamoto S, Kinoshita T, Fujiwara Y, Tamura K.

Cancer Sci. 2017 Jul;108(7):1520-1529. doi: 10.1111/cas.13274. Epub 2017 Jun 14.

50.

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats.

Magaki M, Ishii H, Yamasaki A, Kitai Y, Kametani S, Nakai R, Dabid A, Tsuda H, Ohnishi T.

J Toxicol Pathol. 2017 Apr;30(2):145-152. doi: 10.1293/tox.2016-0052. Epub 2016 Dec 8.

Supplemental Content

Support Center